01 January 2001
Regional cerebral glucose metabolism of patients with malignant diseases indifferent clinical phases.
Manabu Tashiro, Kazuo Kubota, Masatoshi Itoh, Yoichi Nakagawa, Maki Kamada, Yasuo Takahashi, Takashi Yoshioka, Mehedi Masud, Hidetada SasakiMed Sci Monit 2001; 7(2): CR226-232 :: ID: 421158
Abstract
BACKGROUND: Psychological and psychiatric aspects of cancer patients havenot been studied well in terms of functional neuroimaging. The aim of this pilot study was to investigatethe relationship between regional cerebral metabolism and different clinical phases.
MATERIAL AND METHODS:Relative cerebral glucose metabolism of 77 Japanese patients with various types of malignant diseaseswas studied by positron emission tomography with 18F-fluorodeoxyglucose. They were subgrouped into the1) pre-treatment, 2) post-treatment, 3) recurrence and 4) terminal patient groups. These subgroups werecompared to the control group of 17 in-patients with benign diseases, using voxel-based Statistic ParametricalMapping software (SPM).
RESULTS: Relative reduction in the regional cerebral metabolism was detectedin the prefrontal and basolateral (inferolateral) prefrontal cortex, orbitofrontal cortex, anterior andposterior cingulate gyrus, insula, basal ganglia, hippocampus and thalamus in the pre-treatment group.The anterior and posterior cingulate gyri were hypometabolic only in the pre-treatment group. Hypometabolicareas were detected only in the basolateral prefrontal cortex, orbitofrontal cortex, ventral part ofcingulate gyrus and insula in the post-treatment group. In the terminal group, the hypometabolic patternseemed very close to that in the pre-treatment group. The results seemed to suggest that hypometabolicfindings before treatments could reverse after treatments but became prominent again in terminal stages.These results do not contradict with previous epidemiological findings that high incidence of adjustmentdisorders was seen in earlier stages and more brain organic syndromes were seen in terminal stages.
CONCLUSION:It could be speculated that decreased metabolism in early stages reflects state-dependent changes andthat decreased metabolism in the terminal stages reflects organic brain damages. brain of cancer patientsshow a fluctuation in the regional metabolism. This finding might give a suggestion that functional imagingcould be used as a supplementary method for psychological evaluation of patients with severe diseases.
Keywords: cerebral glucose metabolism, cancer patients, PET, Brain
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952